Austar Lifesciences Limited

Equities

6118

KYG0632L1023

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. Other stock markets 04:08:49 2024-05-06 am EDT			5-day change	1st Jan Change
0.71 ^HKD	-2.74%		-6.58%	-54.49%

Mar. 26	Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 22	Austar Lifesciences to Swing to Loss; Shares Drop	MT

Austar Lifesciences Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023

January 19, 2024 at 08:08 am EST

Austar Lifesciences Limited provided consolidated earnings guidance for the year ended 31 December 2023. The group is expected to record a loss attributable to the owners of the company of approximately RMB 110 million for the year ended 31 December 2023 as compared with a profit attributable to the owners of the company of approximately RMB 87 million for the year ended 31 December 2022.

Latest news about Austar Lifesciences Limited

Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Austar Lifesciences to Swing to Loss; Shares Drop	Jan. 22	MT
Austar Lifesciences Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	Jan. 19	CI
Austar Lifesciences Hires New Auditor	Nov. 17	MT
Austar Lifesciences Swings to Loss in H1	23-08-30	MT
Austar Lifesciences Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
ValGenesis, Inc. and AUSTAR Group Partner to Deploy Digital, Risk-Based Solutions for Life Sciences Companies in China	23-08-15	CI
Austar Lifesciences Expects Higher Loss in H1	23-08-03	MT
Austar Lifesciences Limited Updates Consolidated Group Earnings Guidance for the Six Months Ending June 30, 2023	23-08-03	CI
Austar Lifesciences Warns of H1 Loss	23-06-30	MT
Austar Lifesciences Limited Provides Group Earnings Guidance for the Six Months Ending 30 June 2023	23-06-30	CI
Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-28	CI
Austar Lifesciences Expects 2022 Profit to Fall to 50 Million Yuan	23-02-05	MT
Austar Lifesciences Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022	23-02-03	CI
Austar Lifesciences Limited Announces Executive Changes	22-09-27	CI
Austar Lifesciences Limited(SEHK:6118) dropped from S&P Global BMI Index	22-09-19	CI
Austar Lifesciences Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Austar Lifesciences Forecasts H1 Profit Fall to $6.4 Million	22-08-08	MT
Austar Lifesciences Limited acquired an unknown minority interest in Noozle Fluid Technology Co., Ltd..	22-08-07	CI
Austar Lifesciences Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022	22-08-05	CI
Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-25	CI
Austar Lifesciences Completes Buy of Nanjing Bojian's Technology, Ancillary Business; Shares Rise 3%	22-03-02	MT
Austar Lifesciences Limited acquired the Technology and ancillary business of Nanjing Bojian Technology Co., Ltd from Nanjing Bojian Technology Co., Ltd.	22-02-28	CI
Hong Kong Stocks Extend Retreat; Austar Lifesciences Soars 25%	22-01-25	MT
Austar Lifesciences Forecasts Eightfold Increase in FY21 Profit; Shares Rally 24%	22-01-25	MT

Chart Austar Lifesciences Limited

Duration

Period

More charts

Company Profile

Austar Lifesciences Limited is principally engaged in the provision of integrated engineering solutions to pharmaceutical manufactures and research institutes and the manufacture and distribution of pharmaceutical equipment and consumables in China. The Company operates its business through six segments: liquid and bioprocess system segment, clean room and automation control and monitoring system segment, powder and solid system segment, good manufacturing practice (GMP) compliance service segment, life science consumables segment and distribution and agency of pharmaceutical equipment segment.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-25 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
AUSTAR LIFESCIENCES LIMITED	-54.49%	47.9M
ABBOTT LABORATORIES	-3.91%	184B
MEDTRONIC PLC	-0.81%	108B
BECTON, DICKINSON AND COMPANY	-2.48%	67.82B
DEXCOM, INC.	+4.51%	51.05B
CENCORA, INC.	+9.16%	44.67B
HOYA CORPORATION	+3.40%	41.78B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.08%	26.78B
WEST PHARMACEUTICAL SERVICES, INC.	+3.96%	26.59B
TERUMO CORPORATION	+15.23%	25.86B

Other Medical Equipment, Supplies & Distribution